Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery
Current Medical Research and Opinion, 09/24/09
Naslund M et al. – The results suggest that delaying 5ARI therapy in men with BPH increases the risk of AUR and prostate surgery.
Related Articles
Routine evaluation of prostate size not as effective in cancer screening
EurekAlert, 11/11/09
Relevance Score: 95%
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/16/09
Relevance Score: 95%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 95%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 94%
Exercise and Prostate Cancer Risk in a Cohort of Veterans Undergoing Prostate Needle Biopsy
The Journal of Urology, 10/19/09
Relevance Score: 93%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases
Current Medical Research and Opinion, 12/18/09
Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
Clinical Interventions in Aging, 12/18/09
Iron supplementation in the non-dialysis chronic kidney disease patient: oral or intravenous
Current Medical Research and Opinion, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


